Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for minimal function CFTR mutations

Tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for minimal function CFTR mutations

Resource Type

CF Research News

Authors

Anne Munck, Eitan Kerem, Helmut Ellemunter, Daniel Campbell, Linda T Wang, Neil Ahluwalia, Caroline A Owen, Claire Wainwright

References

J Cyst Fibros . 2020 Jun 13;S1569-1993(20)30128-4. doi: 10.1016/j.jcf.2020.04.015.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

Ivacaftor; Tezacaftor [3]

Date

Saturday, June 13, 2020

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [4]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/tezacaftorivacaftor-people-cystic-fibrosis-heterozygous-minimal

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-20-00078R1_FINAL_Munck_270620.pdf [2] https://pubmed.ncbi.nlm.nih.gov/32546431/ [3] https://www.ecfs.eu/research-article-keywords/ivacaftor-tezacaftor [4] https://www.ecfs.eu/resource-guideline-type/other-guidelines